Your browser doesn't support javascript.
loading
Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report.
Ciresi, A; Radellini, S; Guarnotta, V; Giordano, C.
Afiliação
  • Ciresi A; Section of Endocrinology, Diabetology and Metabolic Diseases, Biomedical Department of Internal and Specialist Medicine (DIBIMIS), University of Palermo, Piazza delle Cliniche 2, 90127, Palermo, Italy.
  • Radellini S; Section of Endocrinology, Diabetology and Metabolic Diseases, Biomedical Department of Internal and Specialist Medicine (DIBIMIS), University of Palermo, Piazza delle Cliniche 2, 90127, Palermo, Italy.
  • Guarnotta V; Section of Endocrinology, Diabetology and Metabolic Diseases, Biomedical Department of Internal and Specialist Medicine (DIBIMIS), University of Palermo, Piazza delle Cliniche 2, 90127, Palermo, Italy.
  • Giordano C; Section of Endocrinology, Diabetology and Metabolic Diseases, Biomedical Department of Internal and Specialist Medicine (DIBIMIS), University of Palermo, Piazza delle Cliniche 2, 90127, Palermo, Italy. carla.giordano@unipa.it.
BMC Endocr Disord ; 18(1): 2, 2018 Jan 24.
Article em En | MEDLINE | ID: mdl-29361932

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acromegalia / Somatostatina / Terapia de Salvação / Hormônio do Crescimento Humano / Ergolinas Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Male Idioma: En Revista: BMC Endocr Disord Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acromegalia / Somatostatina / Terapia de Salvação / Hormônio do Crescimento Humano / Ergolinas Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Male Idioma: En Revista: BMC Endocr Disord Ano de publicação: 2018 Tipo de documento: Article